Status:
UNKNOWN
Development of a Non-Invasive DNA Methylation-Based Assay System for the Risk Assessment of Urothelial Carcinoma
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Bladder Cancer
Eligibility:
All Genders
40-80 years
Brief Summary
Bladder cancer ranks the ninth in worldwide cancer incidence. Approximate 90% of bladder cancer is the malignancy of urothelium tissues, the urothelial cancer (UC). The mortality of bladder cancer is ...
Detailed Description
In the recent years, technologies of genomics, expression analysis and proteomics have been brought to guide the study of risk assessment and early detection of cancers. This proposed study aims to de...
Eligibility Criteria
Inclusion
- those with histopathological-confirmed urothelial carcinoma will be included.
Exclusion
- those were younger than 40 years old or with previous history of any other cancers will be excluded.
Key Trial Info
Start Date :
August 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2010
Estimated Enrollment :
82 Patients enrolled
Trial Details
Trial ID
NCT00867620
Start Date
August 1 2008
End Date
July 1 2010
Last Update
March 24 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.